RESUMO
Mayaro virus (MAYV) is an arthropod-borne virus and a member of the family Togaviridae, genus Alphavirus. Its infection leads to an acute illness accompanied by long-lasting arthralgia. To date, there are no antiviral drugs or vaccines against infection with MAYV and resources for the prevention or treatment of other alphaviruses are very limited. MAYV has served as a model to study the antiviral potential of several substances on alphavirus replication. In this work we evaluated the antiviral effect of seven new derivatives of thieno[2,3-b]pyridine against MAYV replication in a mammalian cell line. All derivatives were able to reduce viral production effectively at concentrations that were non-toxic for Vero cells. Molecular modeling assays predicted low toxicity risk and good oral bioavailability of the substances in humans. One of the molecules, selected for further study, demonstrated a strong anti-MAYV effect at early stages of replication, as it protected pre-treated cells and also during the late stages, affecting virus morphogenesis. This study is the first to demonstrate the antiviral effect of thienopyridine derivatives on MAYV replication in vitro, suggesting the potential application of these substances as antiviral molecules against alphaviruses. Additional in vivo research will be needed to expand the putative therapeutic applications.
Assuntos
Alphavirus/efeitos dos fármacos , Antivirais/química , Antivirais/farmacologia , Piridinas/farmacologia , Tiofenos/farmacologia , Animais , Chlorocebus aethiops , Humanos , Piridinas/síntese química , Piridinas/química , Piridinas/toxicidade , Tiofenos/síntese química , Tiofenos/química , Tiofenos/toxicidade , Células Vero , Replicação Viral/efeitos dos fármacosRESUMO
In recent years dengue has become a rapidly growing public health problem worldwide, however, the availability of accurate and affordable diagnostic immunoassays is limited, partly due to the difficulty of producing large quantities of purified antigen. Non-structural protein 1 (NS1) has shown to be a good candidate for inclusion in diagnostic assays and for serosurveys, particularly in endemic countries as a prerequisite for vaccination. In this work the NS1 antigen derived from dengue virus type-1 (DENV1) was expressed in HEK293-T cells and purified by affinity chromatography. The recombinant protein was recovered properly folded as dimers, highly purified and with good yield (1.5 mg/L). It was applied as a serological probe in an indirect ELISA developed in this work to detect human IgG antibodies. Preliminary comparative performance values of 81.1% sensitivity and 83.0% specificity of the developed and preliminary validated iELISA, relative to a commercial kit were obtained, suggesting that the purified recombinant DENV1 NS1 antigen is suitable to detect IgG antibodies, indicative of past DENV infection.
Assuntos
Vírus da Dengue , Dengue , Viroses , Animais , Humanos , Vírus da Dengue/genética , Dengue/diagnóstico , Células HEK293 , Sensibilidade e Especificidade , Anticorpos Antivirais , Proteínas não Estruturais Virais , Ensaio de Imunoadsorção Enzimática/métodos , Imunoglobulina G/metabolismo , MamíferosRESUMO
The SARS-CoV-2 responsible for the ongoing COVID pandemic reveals particular evolutionary dynamics and an extensive polymorphism, mainly in Spike gene. Monitoring the S gene mutations is crucial for successful controlling measures and detecting variants that can evade vaccine immunity. Even after the costs reduction resulting from the pandemic, the new generation sequencing methodologies remain unavailable to a large number of scientific groups. Therefore, to support the urgent surveillance of SARS-CoV-2 S gene, this work describes a new feasible protocol for complete nucleotide sequencing of the S gene using the Sanger technique. Such a methodology could be easily adopted by any laboratory with experience in sequencing, adding to effective surveillance of SARS-CoV-2 spreading and evolution.
Assuntos
Teste de Ácido Nucleico para COVID-19/métodos , COVID-19/diagnóstico , COVID-19/epidemiologia , Genes Virais , Pandemias/prevenção & controle , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , SARS-CoV-2/genética , Análise de Sequência de RNA/métodos , Glicoproteína da Espícula de Coronavírus/genética , Sequência de Bases , Brasil/epidemiologia , COVID-19/virologia , Testes Diagnósticos de Rotina/métodos , Eletroforese em Gel de Ágar/métodos , Monitoramento Epidemiológico , Humanos , Mutação , RNA Viral/genética , RNA Viral/isolamento & purificaçãoRESUMO
BACKGROUND: The arthropod-borne Mayaro virus (MAYV) causes "Mayaro fever," a disease of medical significance, primarily affecting individuals in permanent contact with forested areas in tropical South America. Recently, MAYV has attracted attention due to its likely urbanization. There are currently no licensed drugs against most mosquito-transmitted viruses. Punica granatum (pomegranate) fruits cultivated in Brazil have been subjected to phytochemical investigation for the identification and isolation of antiviral compounds. In the present study, we explored the antiviral activity of pomegranate extracts in Vero cells infected with Mayaro virus. METHODS: The ethanol extract and punicalagin of pomegranate were extracted solely from the shell and purified by chromatographic fractionation, and were chemically identified using spectroscopic techniques. The cytotoxicity of the purified compounds was measured by the dye uptake assay, while their antiviral activity was evaluated by a virus yield inhibition assay. RESULTS: Pomegranate ethanol extract (CC50 = 588.9, IC50 = 12.3) and a fraction containing punicalagin as major compound (CC50 = 441.5, IC50 = 28.2) were shown to have antiviral activity (SI 49 and 16, respectively) against Mayaro virus, an alphavirus. Immunofluorescence analysis showed the virucidal effect of pomegranate extract, and transmission electron microscopy (TEM) revealed damage in viral particles treated with this extract. CONCLUSIONS: The P. granatum extract is a promising source of antiviral compounds against the alphavirus MAYV and represents an excellent candidate for future studies with other enveloped RNA viruses.
Assuntos
Alphavirus/efeitos dos fármacos , Antivirais/farmacologia , Arbovírus/efeitos dos fármacos , Culicidae/virologia , Compostos Fitoquímicos/farmacologia , Punica granatum/química , Replicação Viral/efeitos dos fármacos , Alphavirus/classificação , Animais , Chlorocebus aethiops , Taninos Hidrolisáveis/farmacologia , Células VeroRESUMO
Dengue virus (DENV), an arbovirus transmitted by mosquitoes, has become a major threat to American human life, reaching approximately 23 million cases from 1980 to 2017. Brazil is among the countries most affected by this terrible viral disease, with 13.6 million cases. DENV has four different serotypes, DENV1-4, which show a broad clinical spectrum. Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector control strategies, early disease diagnostics and the development of vaccines and antiviral drugs are priorities. In this study, we present the probable origins of dengue in America and the trajectories of its spread. Overall, dengue diagnostics are costly, making the monitoring of dengue epidemiology more difficult and affecting physicians' therapeutic decisions regarding dengue patients, especially in developing countries. This review also highlights some recent and important findings regarding dengue in Brazil and the Americas. We also summarize the existing DENV polymerase chain reaction (PCR) diagnostic tests to provide an improved reference since these tests are useful and accurate at discriminating DENV from other flaviviruses that co-circulate in the Americas. Additionally, these DENV PCR assays ensure virus serotyping, enabling epidemiologic monitoring.
Assuntos
Vírus da Dengue/isolamento & purificação , Dengue/diagnóstico , Dengue/epidemiologia , América/epidemiologia , Dengue/história , Dengue/patologia , História do Século XIX , História do Século XX , História do Século XXI , HumanosRESUMO
Non-steroidal and anti-inflammatory drugs (NSAIDs) are a class of pharmacological agents that are tradicionally used for their anti-cyclooxigenase properties in the treatment of inflammation and other associated diseases. Recently, however, it has been demonstrated that several NSAIDs exhibit antiproliferative effects in various animal models and in vitro experiments. In this paper we demonstrated that treatment of Aedes albopictus cells (mosquito) with indomethacin results in a reduction of normal growth rate. Cells treated with 100 mM indomethacin exhibited a profound time dependent reduction in their proliferation rate over the 96 h test period.